tradingkey.logo
tradingkey.logo
Suchen

Catheter Precision Inc

VTAK
Zur Watchlist hinzufügen
0.790USD
-0.085-9.83%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
2.13MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Catheter Precision Inc Unternehmen

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.

Catheter Precision Inc Informationen

BörsenkürzelVTAK
Name des UnternehmensCatheter Precision Inc
IPO-datumSep 27, 2018
CEOJenkins (David A)
Anzahl der mitarbeiter22
WertpapierartOrdinary Share
GeschäftsjahresendeSep 27
Addresse1670 Highway 160 West
StadtFORT MILL
BörseNASDAQ OMX – NASDAQ Basic Amex
LandUnited States of America
Postleitzahl29708
Telefon19736912000
Websitehttps://www.ramed.com/
BörsenkürzelVTAK
IPO-datumSep 27, 2018
CEOJenkins (David A)

Führungskräfte von Catheter Precision Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
48.49K
+54.05%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
48.49K
+54.05%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Catheter Precision Inc?

Die fünf größten Anteilseigner von Catheter Precision Inc sind: Mr. David Jenkins

Wie viele Institutionen halten Anteile an Catheter Precision Inc (VTAK)?

Mit Stand vom 2026Q1 halten 28 Institutionen Anteile an Catheter Precision Inc, mit einem Gesamtmarktwert von etwa 304.48K, was 11.31% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 230261.00 gestiegen.